A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

Title : A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

Source : Cochrane
ID : 29288137
Authors : Donovan, , JL, Young, GJ, Walsh, EI, Metcalfe, C, Lane, JA, Martin, RM, Tazewell, MK, Davis, M, Peters, TJ, Turner, EL, Mills, N, Khazragui, H, Khera, TK, Neal, DE, Hamdy, FC, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Holding, P, Hughes, O, Kockelbergh, R, Kynaston, H, Mason, M, Oxley, J, Paul, A, Paez, E, Rosario, DJ, Rowe, E; Staffurth, J
Year : 2018
Disease Category : Cancer
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Trial participants v.s. non-participants (excluded by the trial, or eligible but non-randomized) : Yes
Real-world data sources : Trial data
Target Population Data Type Levels : Trial